Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Nasdaq
NDAQ
$55.2B
| $21.6M | 0.04% |
1,216,107
+767,919
| +171% | +$13.2M |
|
527
Pediatrix Medical
MD
$2.16B
| $21.6M | 0.04% |
281,428
+162,383
| +136% | +$13.1M |
|
|
AAT
528
American Assets Trust
AAT
$1.41B
| $21.6M | 0.04% |
528,327
-62,839
| -11% | -$2.53M |
|
529
Republic Services
RSG
$68.3B
| $21.6M | 0.04% |
523,694
+510,120
| +3,758% | +$21M |
|
|
VIAB
530
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $21.6M | 0.04% |
+500,000
| New | +$24.8M |
|
|
SPNC
531
DELISTED
Spectranetics Corp
SPNC
| $21.5M | 0.04% |
1,824,598
-77,667
| -4% | -$1.39M |
|
532
First Industrial Realty Trust
FR
$8.41B
| $21.5M | 0.04% |
1,025,611
-207,514
| -17% | -$4.17M |
|
533
Commault Systems
CVLT
$5.43B
| $21.5M | 0.04% |
632,492
+387,016
| +158% | +$14.4M |
|
534
Allstate
ALL
$65.8B
| $21.4M | 0.04% |
368,138
-325,929
| -47% | -$20.4M |
|
535
Union Pacific
UNP
$184B
| $21.4M | 0.04% |
242,220
-16,067
| -6% | -$1.47M |
|
536
Jazz Pharmaceuticals
JAZZ
$16.5B
| $21.4M | 0.04% |
161,228
+71,419
| +80% | +$12.3M |
|
537
Nelnet
NNI
$4.57B
| $21.4M | 0.04% |
618,066
-39,129
| -6% | -$1.54M |
|
538
Constellation Brands
STZ
$23.5B
| $21.4M | 0.04% |
170,653
-13,239
| -7% | -$1.63M |
|
539
Skyworks Solutions
SWKS
$10.1B
| $21.3M | 0.04% |
253,368
+23,651
| +10% | +$2.16M |
|
|
BNY
540
Bank of New York Mellon
BNY
$110B
| $21.3M | 0.04% |
544,212
-4,220,406
| -89% | -$175M |
|
541
iShares Silver Trust
SLV
$33.5B
| $21.3M | 0.04% |
1,534,921
-1,578,718
| -51% | -$22.5M |
|
542
Teleflex
TFX
$5.86B
| $21.3M | 0.04% |
+171,265
| New | +$22.9M |
|
|
APC
543
CALL
DELISTED
Anadarko Petroleum
APC
| $21.3M | 0.04% |
352,100
| – | – |
|
|
CBI
544
PUT
DELISTED
Chicago Bridge & Iron Nv
CBI
| $21.2M | 0.04% |
534,100
+166,800
| +45% | +$7.72M |
|
545
Brinker International
EAT
$10.9B
| $21.1M | 0.04% |
401,403
+362,110
| +922% | +$20.2M |
|
546
Cencora
COR
$61.8B
| $21.1M | 0.04% |
221,663
-430,136
| -66% | -$45.1M |
|
|
CPN
547
DELISTED
Calpine Corporation
CPN
| $21M | 0.04% |
1,440,965
+913,408
| +173% | +$15M |
|
|
GHDX
548
DELISTED
Genomic Health, Inc.
GHDX
| $21M | 0.04% |
993,528
+553,649
| +126% | +$14.3M |
|
|
WCG
549
DELISTED
Wellcare Health Plans, Inc.
WCG
| $21M | 0.04% |
243,925
+116,221
| +91% | +$10.2M |
|
550
Snap-on
SNA
$20.4B
| $21M | 0.04% |
139,179
+42,148
| +43% | +$6.76M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.